以下文章来源于霞光社 ，作者岭南人鱼机 霞光社 . 赋能企业全球化 日本消费者的钱包，还有得赚。 来源： 霞光社 作者：岭南人鱼机 "经济上行的美"成为今年上半年的流行词，带着对昨日生机勃勃的浓烈怀旧气息，击中了无数 年轻人的心。 2025年Q1，日本GDP再次出现负增长，这意味着自1989年日本泡沫经济破裂后，经济停滞 的状态已经长达35年之久。期间，日本GDP全球占比从1989年的约15.3% [1] 降至2022年的 4.18%，GDP总量从位居全球第二，先后在2010年、2023年被中国、德国超越，跌至全球第 四。 而耐人寻味的是，在日本经济持续疲软的当下，多家中国新兴电商却开始将目的地看向这 一"失落地"。6月30日，TikTok宣布在日本推出TikTok Shop，购物功能正式上线，允许卖 家进军这一全球第三大电商市场 （据Statista Market Insights数据，日本以1690亿美元的 市场表现排在全球第三） 。此外，Temu、TAO （阿里巴巴旗下） 、京东日本站分别于 2023~2024年期间登陆日本，SHEIN也于2020年末在日本上线。 如果说"经济上行的美"是一种向前奔跑的 ...

尹莹/作者 李彦/编辑 化妆品那些事/出品 头图/截自品牌官网 植物医生要上市了。 6月27日，据深交所官网披露，北京植物医生化妆品股份有限公司（以下简称"植物医生"）主板IPO申请获受理，保荐机构为中信证券，企业拟公开发行新股 数量不超过2666.67万股，占本次发行后总股本的比例不低于25%。 据招股书披露的信息，植物医生2022年至2024年间公司分别实现主营业务收入21.16亿元、21.50亿元和21.55亿元，净利润分别为1.68亿元、2.29亿元和2.42亿 元，公司主营业务毛利率分别为55.22%、60.34%和58.90%。截至2025年5月31日，公司拥有481家分公司。 | | | | 里位: 力元 | | --- | --- | --- | --- | | 主营业务收入 | 2024 年度 | 2023 年度 | 2022 年度 | | 其他上市公司中位数 | 137,596.57 | 147,524.18 | 131.107.18 | | 植物医生 | 215,496.81 | 215,000.49 | 211.621.61 | | 净利润 | 2024 年度 | 2023 年度 | ...

洞见 （ DJ00123987 ） —— 不一样的观点，不一样的故事， 3000 万人订阅的微信大号。点击标题下 蓝字 " 洞见 " 关注，我们将为您提供有价值、有意思的延伸阅读。 在节奏不断加快、选择愈发多元的当下，年轻人的目光，正悄然从 "外部指标" 移向 "内在坐 标" 。 2025年，我们越来越真切地感受到一代人的集体转向—寺庙上香、躺平、丁克、逃离……这些 行为看似脱离主流，却实实在在地反映出一种趋势： 新时代正在集体失焦，也在尝试重新校准自己的生命坐标，关注自我内核。 在不确定成为常态的今天，这样的"向内走"并非退让，而是一种有意识的自我建构。他们正在 从被外部定义的轨道中抽身，回望内心的真实渴望。 他们不再急于破土而出，而是选择在不确定中向内扎根，用稳定的内核对抗时代的变动。 在充 满变量的现实中，守住自己的节奏 ，不跟风、不赶路，才是他们重新建立安全感与自洽感的方 式。 01 从外部指标到心灵坐标：年轻人开始寻找内核支点。 不再执念于所谓"黄金十年"，越来越多年轻人选择放下内卷与比较。他们开始意识到，稳定的 内核，才是穿越不确定的根源力量。 真正的方向感来自内在—他们不再向外寻求标准答案，而是 ...

Core Viewpoint - The recent investigation by the China Securities Regulatory Commission (CSRC) into Jinsong New Materials highlights a significant trust crisis for the company, stemming from long-standing operational issues, including continuous losses, high customer concentration, and industry challenges [1]. Group 1: Operational Challenges - Jinsong New Materials reported a revenue of 333 million yuan in 2024 but incurred a net loss of 22.65 million yuan, continuing into Q1 2025 with a loss of 3.836 million yuan [2]. - The company's heavy asset model, with a 66,000 square meter factory and over 900 employees, has become a burden due to increased depreciation amid fluctuating orders [2]. - The reliance on major clients like L'Oréal and Estée Lauder has led to a precarious revenue model, exposing the company to risks from exchange rate fluctuations and tariff policies, as 50% of its business is based on FOB settlements [2]. Group 2: Governance Issues - The CSRC's investigation reveals deep governance issues within the company, particularly the concentrated ownership structure, with the controlling family holding 23.11% of voting rights, raising concerns about internal control failures [3]. - The lack of transparency regarding specific violations and the frequent "normal operations" announcements amid ongoing losses have led to market skepticism about the company's financial health [3]. - Following the investigation announcement, the company's stock experienced a single-day volatility exceeding 16%, indicating a loss of investor confidence and increased financing difficulties [3]. Group 3: Industry Context - Jinsong New Materials represents a failed case in the transformation of Chinese manufacturing, focusing too much on its status as a leading acrylic container producer while neglecting core process control and innovation [4]. - The company faces increasing competition from both established brands and new entrants in the cosmetics packaging sector, which could easily replace Jinsong as major clients build their own packaging facilities [4]. - Without a shift from being perceived as a mere contract manufacturer to a developer of materials and ESG standards, Jinsong New Materials may face escalating operational challenges [4].

Core Viewpoint - The incident involving a consumer's complaint about a facial mask highlights a trust crisis within the beauty industry, particularly regarding product quality and consumer safety [1][4]. Company Overview - The company in question, Xi'an Juzhi Biological Technology Co., Ltd., was established in 2000 and went public on the Hong Kong Stock Exchange in 2022. It owns several brands, including Kefu Mei and Keli Jin, with Kefu Mei being a major product line [10]. - The company reported a revenue of 5.539 billion yuan for 2024, reflecting a year-on-year growth of 57.2%, and a net profit of 2.062 billion yuan, up 42.1% year-on-year. Kefu Mei accounted for 82% of the total revenue, with its sales increasing by 62.9% to 4.542 billion yuan [10]. Industry Context - The beauty industry is currently facing significant scrutiny over product safety and quality, as evidenced by multiple complaints against Juzhi Biological, including allegations of misleading advertising and unapproved ingredients [10]. - The company's research and development (R&D) investment appears to be insufficient, with an R&D expense ratio of only 1.9% in 2024, down from 2.1% in 2023. In comparison, competitors like Jinbo Biological, Huaxi Biological, and Beitaini have R&D expense ratios of 10.89%, 6.8%, and 6.07%, respectively [10].

以下文章来源于霞光社 ，作者岭南人鱼机 霞光社 . 赋能企业全球化 "经济上行的美"成为今年上半年的流行词，带着对昨日生机勃勃的浓烈怀旧气息，击中了无数年轻人的心。 2025年Q1，日本GDP再次出现负增长，这意味着自1989年日本泡沫经济破裂后，经济停滞的状态已经长达 35年之久。期间，日本GDP全球占比从1989年的约15.3%[1]降至2022年的4.18%，GDP总量从位居全球第 二，先后在2010年、2023年被中国、德国超越，跌至全球第四。 而耐人寻味的是，在日本经济持续疲软的当下，多家中国新兴电商却开始将目的地看向这一"失落地"。6月 30日，TikTok宣布在日本推出TikTok Shop，购物功能正式上线，允许卖家进军这一全球第三大电商市场 （据Statista Market Insights数据，日本以1690亿美元的市场表现排在全球第三）。此外，Temu、TAO（阿里 巴巴旗下）、京东日本站分别于2023-2024年期间登陆日本，SHEIN也于2020年末在日本上线。 | 平台 | 上线时间 | 用户规模 | 核心策略 | | --- | --- | --- | --- | | SHEI ...

Core Viewpoint - L'Oréal Group has signed an agreement to acquire the hair care brand Color Wow, with the transaction expected to be completed upon regulatory approval and fulfillment of other customary conditions [1] Company Summary - The acquisition of Color Wow is part of L'Oréal's strategy to expand its portfolio in the hair care segment [1] - The deal highlights L'Oréal's commitment to enhancing its presence in the beauty and personal care market [1] Industry Summary - The hair care market continues to see consolidation as major players seek to strengthen their brand offerings through acquisitions [1] - This acquisition reflects ongoing trends in the beauty industry where companies are increasingly focusing on niche brands to capture specific consumer segments [1]

风波后，李吉感觉到货物渐渐卖不动了，接到的订单销量相比 今年4月下滑了60%至70%，胶原棒2.0在风波前平均一天能 卖200盒，到现在平均一周只能走几盒。 作者：罗文利 封图：图虫创意 7月1日，一款原本在市面上热卖的护肤产品，同行在群里喊出了一盒只卖150元，这个价格低于李 吉的拿货价格，他坚决不能接受。 李吉是做护肤品生意的个体户，这款产品为可复美重组胶原蛋白御肌修护次抛精华液（下称"可复 美胶原棒2.0"），每盒包含30支1.5ml的胶原棒，在京东官方旗舰店的价格为379元/盒。胶原棒2.0 此前卖得好，李吉囤了不少货。 可复美是巨子生物控股有限公司（02367.HK，下称"巨子生物"）旗下核心品牌，以重组胶原蛋白 为主要成分，主要产品涵盖次抛精华、敷料面膜等。2024年，可复美的销售收入为45.4亿元，占 巨子生物营收的82%。 然而在过去约40天内，可复美胶原棒2.0遭遇外界对其重组胶原蛋白成分含量的质疑，引发了市场 对巨子生物产品质量及宣传真实性的怀疑，风波至今未平。 也是从5月24日开始，李吉作为可复美的下游个体经销商，生意遭受重创： 可复美胶原棒2.0的销 量相较今年 4月份下滑了60%至7 ...

Core Insights - The beauty industry is increasingly entering the outdoor sports scene, with brands like Estée Lauder, Juhua, and L'Oréal responding to the growing demand for outdoor beauty products among consumers [1] - The number of registered cosmetics-related companies in China has shown a significant increase, with 5.65 million new registrations in 2023, marking a 51.35% year-on-year growth [2] - Over half of the existing cosmetics-related companies were established in the last three years, indicating a rapid influx of new entrants into the market [4] Group 1: Company Growth - There are currently 20.7343 million cosmetics-related companies in China, with a steady increase in registrations over the past decade [2] - In 2024, it is projected that 5.1884 million new cosmetics-related companies will be registered, although this represents a decline from the previous year [2] - As of now, 2.4755 million companies have been registered in 2023 [2] Group 2: Regional Distribution - New registrations of cosmetics-related companies are predominantly concentrated in Central China, contributing 31.24% to the total [3] - Eastern and Southern China follow, with contribution rates of 25.33% and 18.29% respectively [3] Group 3: Company Age - More than half of the existing cosmetics-related companies have been established in the last three years, with those founded within 1-3 years making up 33.49% of the total [4] - Companies established within the last year account for 22.17%, while those in operation for over ten years represent 6.41% [4]

可复美是巨子生物控股有限公司（02367.HK，下称"巨子生物"）旗下核心品牌，以重组胶原蛋白为主要成分，主要产品涵盖次抛精华、敷料面膜等。2024 年，可复美的销售收入为45.4亿元，占巨子生物营收的82%。 然而在过去约40天内，可复美胶原棒2.0遭遇外界对其重组胶原蛋白成分含量的质疑，引发了市场对巨子生物产品质量及宣传真实性的怀疑，风波至今未 平。 7月1日，一款原本在市面上热卖的护肤产品，同行在群里喊出了一盒只卖150元，这个价格低于李吉的拿货价格，他坚决不能接受。 李吉是做护肤品生意的个体户，这款产品为可复美重组胶原蛋白御肌修护次抛精华液（下称"可复美胶原棒2.0"），每盒包含30支1.5ml的胶原棒，在京东官 方旗舰店的价格为379元/盒。胶原棒2.0此前卖得好，李吉囤了不少货。 也是从5月24日开始，李吉作为可复美的下游个体经销商，生意遭受重创：可复美胶原棒2.0的销量相较今年4月份下滑了60%至70%。 这个时间段正好赶上了美妆品牌重要的销售节点——"6·18"。 在2023年和2024年，可复美的"6·18"GMV（商品交易总额）在天猫、抖音电商平台的排名中逐年攀升，但今年是其近三年首次排名 ...